AI Portfolio Summary
In 2026 Q1, Tetragon Partners GP Ltd maintained a portfolio of 40 distinct positions. The most significant new addition to the portfolio was WARNER BROS DISCOVER, which now represents 4.92% of the total fund value. They heavily accumulated shares in UIPATH INC, increasing their position by 44.5%. Conversely, Tetragon Partners GP Ltd completely exited their position in AVADEL PHARMACEUTICA.
Total Positions
40
Quarter
2026 Q1
Top Holding
PATH (54.3%)
Top 10 Concentration
82.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-40 of 40
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
PATH
UIPATH INC
|
Technology | 54.32% | 60.30% |
#1
Prev: #1
|
8.5 | 7,757,628 | 44.5% |
P
S
|
25,207,628 | $279,804,671 | 2022 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
KGEI
KOLIBRI GLOBAL ...
|
Energy | 7.28% | 5.75% |
#2
Prev: #2
|
4.9 | -100,000 | -1.4% |
P
S
|
6,834,504 | $37,521,427 | 2023 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
WBD
WARNER BROS DIS...
|
Communication Services | 4.92% | — |
#3
Prev: #—
|
6.5 | 923,725 | no change |
NEW
|
923,725 | $25,365,489 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
WK
WORKIVA INC
|
Technology | 2.89% | 2.73% |
#4
2
Prev: #6
|
4.7 | 100,000 | 66.7% |
P
S
|
250,000 | $14,907,500 | 2025 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
LYFT
LYFT INC
|
Technology | 2.58% | 4.08% |
#5
2
Prev: #3
|
2.5 | no change | no change |
P
S
|
1,000,000 | $13,300,000 | 2019 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CXM
SPRINKLR INC
|
Technology | 2.56% | 3.61% |
#6
1
Prev: #5
|
2.0 | no change | no change |
P
S
|
2,200,000 | $13,200,000 | 2022 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
AUTL
AUTOLUS THERAPE...
|
Healthcare | 2.55% | 3.99% |
#7
3
Prev: #4
|
2.0 | no change | no change |
P
S
|
9,500,000 | $13,110,000 | 2018 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CLDX
CELLDEX THERAPE...
|
Healthcare | 1.92% | 1.40% |
#8
1
Prev: #9
|
3.3 | 68,516 | 28.1% |
P
S
|
312,316 | $9,906,664 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ARWR
ARROWHEAD PHARM...
|
Healthcare | 1.55% | 1.36% |
#9
1
Prev: #10
|
3.1 | 30,263 | 31.2% |
P
S
|
127,198 | $7,975,315 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
NKTR
NEKTAR THERAPEU...
|
Healthcare | 1.44% | 0.62% |
#10
12
Prev: #22
|
3.1 | 33,750 | 48.7% |
P
S
|
103,037 | $7,413,512 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ANNX
ANNEXON INC
|
Healthcare | 1.39% | 2.15% |
#11
4
Prev: #7
|
0.6 | -740,000 | -36.4% |
P
S
|
1,292,455 | $7,160,201 | 2024 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
PHVS
PHARVARIS N V
|
Healthcare | 1.22% | 1.14% |
#12
1
Prev: #11
|
2.5 | 26,999 | 13.9% |
P
S
|
221,611 | $6,260,511 | 2025 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
AXSM
CALL
AXSOME THERAPEU...
|
CALL Option | 1.15% | — |
#13
Prev: #—
|
4.0 | 35,000 | no change |
NEW
|
35,000 | $5,915,700 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ALKS
ALKERMES PLC
|
Healthcare | 1.10% | 0.83% |
#14
4
Prev: #18
|
2.4 | 18,619 | 13.2% |
P
S
|
159,791 | $5,650,210 | 2025 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
AGIO
AGIOS PHARMACEU...
|
Healthcare | 1.08% | 0.93% |
#15
1
Prev: #16
|
0.9 | 2,821 | 1.7% |
P
S
|
164,839 | $5,576,503 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
IMVT
IMMUNOVANT INC
|
Healthcare | 1.05% | 0.89% |
#16
1
Prev: #17
|
2.9 | 52,320 | 31.5% |
P
S
|
218,507 | $5,427,714 | 2025 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
PRAX
PRAXIS PRECISIO...
|
Healthcare | 1.00% | 1.43% |
#17
9
Prev: #8
|
0.4 | -7,000 | -30.5% |
P
S
|
15,952 | $5,139,575 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
KRYS
KRYSTAL BIOTECH...
|
Healthcare | 0.99% | 0.61% |
#18
5
Prev: #23
|
3.4 | 7,854 | 66.5% |
P
S
|
19,668 | $5,080,638 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
DYN
DYNE THERAPEUTI...
|
Healthcare | 0.91% | 1.02% |
#19
6
Prev: #13
|
0.9 | 10,135 | 4.1% |
P
S
|
258,132 | $4,679,933 | 2025 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
AMLX
AMYLYX PHARMACE...
|
Healthcare | 0.86% | 0.69% |
#20
Prev: #20
|
2.3 | 45,049 | 16.5% |
P
S
|
317,877 | $4,418,490 | 2025 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
MBX
MBX BIOSCIENCES...
|
Healthcare | 0.84% | 0.95% |
#21
7
Prev: #14
|
0.8 | 2,153 | 1.5% |
P
S
|
145,480 | $4,342,578 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
DFTX
DEFINIUM THERAP...
|
Healthcare | 0.73% | — |
#22
Prev: #—
|
3.8 | 199,994 | no change |
NEW
|
199,994 | $3,779,887 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
SLNO
SOLENO THERAPEU...
|
Healthcare | 0.66% | — |
#23
Prev: #—
|
3.8 | 102,125 | no change |
NEW
|
102,125 | $3,419,145 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
AXSM
AXSOME THERAPEU...
|
Healthcare | 0.66% | 1.04% |
#24
12
Prev: #12
|
0.3 | -6,875 | -25.5% |
P
S
|
20,059 | $3,390,372 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
HRMY
HARMONY BIOSCIE...
|
Healthcare | 0.65% | 0.65% |
#25
4
Prev: #21
|
2.8 | 36,516 | 44.1% |
P
S
|
119,340 | $3,342,713 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
SLN
SILENCE THERAPE...
|
Healthcare | 0.64% | 0.47% |
#26
1
Prev: #25
|
3.3 | 264,792 | 72.5% |
P
S
|
630,161 | $3,320,948 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ACAD
ACADIA PHARMACE...
|
Healthcare | 0.62% | — |
#27
Prev: #—
|
3.7 | 144,620 | no change |
NEW
|
144,620 | $3,219,241 | 2025 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
IONS
IONIS PHARMACEU...
|
Healthcare | 0.61% | — |
#28
Prev: #—
|
3.7 | 41,764 | no change |
NEW
|
41,764 | $3,136,059 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
MPLT
MAPLIGHT THERAP...
|
Healthcare | 0.44% | 0.61% |
#29
5
Prev: #24
|
0.2 | -52,410 | -31.9% |
P
S
|
112,115 | $2,279,298 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
RLAY
RELAY THERAPEUT...
|
Healthcare | 0.35% | — |
#30
Prev: #—
|
3.6 | 181,543 | no change |
NEW
|
181,543 | $1,806,353 | 2025 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
SNOW
SNOWFLAKE INC
|
Technology | 0.29% | 0.46% |
#31
5
Prev: #26
|
1.1 | no change | no change |
P
S
|
10,000 | $1,508,200 | 2020 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
AARD
AARDVARK THERAP...
|
Healthcare | 0.23% | — |
#32
Prev: #—
|
3.6 | 316,621 | no change |
NEW
|
316,621 | $1,193,661 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
TECX
TECTONIC THERAP...
|
Healthcare | 0.23% | — |
#33
Prev: #—
|
3.6 | 37,588 | no change |
NEW
|
37,588 | $1,161,845 | 2025 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
RARE
ULTRAGENYX PHAR...
|
Healthcare | 0.16% | — |
#34
Prev: #—
|
3.6 | 39,473 | no change |
NEW
|
39,473 | $826,959 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
KPTI
KARYOPHARM THER...
|
Healthcare | 0.06% | — |
#35
Prev: #—
|
3.5 | 52,984 | no change |
NEW
|
52,984 | $295,121 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
KPTI
CALL
KARYOPHARM THER...
|
CALL Option | 0.05% | — |
#36
Prev: #—
|
3.5 | 50,000 | no change |
NEW
|
50,000 | $278,500 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
AVDL
AVADEL PHARMACE...
|
Unknown | 0.00% | 0.20% |
Sold All 😨
(Was: #28) |
0.0 | -43,763 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ZVRA
ZEVRA THERAPEUT...
|
Healthcare | 0.00% | 0.36% |
Sold All 😨
(Was: #27) |
0.0 | -192,518 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
FOLD
AMICUS THERAPEU...
|
Healthcare | 0.00% | 0.78% |
Sold All 😨
(Was: #19) |
0.0 | -260,771 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
RAPT
RAPT THERAPEUTI...
|
Healthcare | 0.00% | 0.94% |
Sold All 😨
(Was: #15) |
0.0 | -131,770 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 |
Showing 1-40 of 40 holdings